© Copyright khedmeh Wall
Creative Diagnostics announces the availability of Vomitoxin Test Reagents for the detection of Deoxynivalenol in food products.
Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, proudly announces the availability of a comprehensive portfolio of Vomitoxin Test Reagents for the detection of Deoxynivalenol in food products, including ELISA Kits, antibodies and Immunoaffinity Columns.
Mycotoxins are toxic metabolites produced by various species of fungi, mainly belonging to the genera Aspergillus, Penicillium and Fusarium. They usually enter the food chain through contaminated food and feed crops (mainly cereals) and cause serious acute and chronic health effects in humans and animals. Therefore, mycotoxin analysis of food and feed is necessary and often required by law.
Deoxynivalenol (DON, also known as vomitoxin) is a sesquiterpenoid compound found in Fusarium graminearum (roseum), F. culmorum and other species. As one of the most common mycotoxins, DON is commonly found in many plant products, especially in cereal crops such as wheat, corn, barley, oats, and rice.
In the higher and more severe stages of contamination, symptoms associated with vomitoxin are much more severe and include abdominal pain, dizziness, headache, throat irritation, nausea, vomiting, diarrhea, and blood in the stool. In animals, DON-contaminated feed can lead to refusal to eat, vomiting or diarrhea, which can inhibit growth. dON testing is an important preventative tool for maintaining the health and productivity of production animals.
Creative Diagnostics has developed high quality test reagents to support the development of mycotoxin detection. Through years of research and experience of its technical staff, the company has successfully developed a range of antigens and antibodies for use in immunoassays and have established a complete set of mycotoxin detection platforms. The newly released Vomitoxin Test Reagents are manufactured under strict quality control procedures and offer excellent performance.
For example, the Deoxynivalenol (DON) ELISA Kit (DEIA056) can be used for the rapid qualitative and quantitative detection of Deoxynivalenol in grain and feed. This kit adopts “direct competition method” enzyme immunoassay technology and is a new generation of drug residue detection kit. It is fast, convenient, accurate and sensitive. The operation time is only 20 minutes, which can minimize the operation error and workload. It should be noted that this is a laboratory reagent and should not be administered to humans or animals or used as a drug.
Creative Diagnostics is committed to providing high quality and reliable testing solutions to the food and feed industries. The company’s new Vomitoxin Test Reagents offer unparalleled accuracy and sensitivity. To learn more information and to explore Creative Diagnostics’ comprehensive product portfolio, please visit https://www.creative-diagnostics.com/food-analysis/tag-don-vomitoxin-34.htm.
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples. Its product portfolio covers a wide range of analytes including mycotoxins, drug residues, pesticides, contaminants, food allergens, food pathogens and vitamins. The company also assists customers in the rapid development, manufacture and commercialization of small molecule antigens, antibodies and food safety lateral flow strips for any market segment.
Creative Diagnostics announces the launch of ELISA Based Assays for vaccine development and bioprocess applications.
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine development and bioprocess applications.
Vaccine development involves a variety of assays to support vaccine research and development, from early preclinical studies to final production, quality control and lot release. ELISA-based assays are widely used to measure vaccine titers, carrier titers, purity, affinity and potency, as well as immunogenic responses in animals and humans.
ELISA-based immunoassays are the gold standard for various aspects of vaccine bioanalysis, including quantification of antigenic epitopes, detection of contaminants, and determination of vaccine efficacy (e.g., vaccine titer and immunogenicity). They are crucial for vaccine bioanalysis, but limitations exist, such as high reagent and sample consumption, diverse sample types, and time-consuming procedures. To address these issues, researchers are exploring improved immunoassays to minimize the use of valuable reagents (e.g., vaccine candidate molecules) and small animal samples, handle different sample types such as serum, plasma, and preparations containing aluminum particles and emulsions, and reduce hands-on time to shorten assay development time.
Creative Diagnostics is committed to providing innovative and reliable solutions to advance vaccine development and bioprocess efficiency. With its expertise in ELISA-based assays, the company empowers researchers and manufacturers to effectively measure vaccine titer, vector titer, purity, potency, and immunogenic response, ultimately contributing to the development of safe and effective vaccines.
For example, Creative Diagnostics can help researchers determine viral vector particle concentrations (titers). Viral vector vaccines are live viruses genetically engineered to express one or more heterologous antigens. Determination of vector particle concentration is an important step in the development and production of such vaccines. Creative Diagnostics now offers high quality ELISA kits for the determination of titers of a range of AAV serotypes or lentiviruses (p24).
In addition, Creative Diagnostics can assist in the detection of antigen-specific antibodies in serum and in antigen quantification and comparison of vaccine lots for release testing. By providing expertise and comprehensive solutions, Creative Diagnostics enables researchers and manufacturers to advance vaccine development and bioprocess efficiency.
Creative Diagnostics also offers a comprehensive range of high-quality ELISA kits for the detection of viral antigens and antibodies. With extensive experience in custom assay development and validation, the Creative Diagnostics team of experts ensures customized solutions to support customer needs. Utilizing extensive reference control and standard materials, Creative Diagnostics delivers reliable qualitative and quantitative testing. Additionally, the company’s holistic study design considers pretesting requirements, sampling modes, detection methods, and assay sensitivities, resulting in effective viral ELISA-based assays.
By offering a comprehensive suite of ELISA-based solutions and unparalleled scientific expertise, Creative Diagnostics empowers researchers and developers to streamline their vaccine development and bioprocess workflows. For more information on the ELISA Based Assays, please visit https://antiviral.creative-diagnostics.com/elisa-based-assays.html.
About Creative Diagnostics
Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.